Review





Similar Products

endothelial lined blood vessel marker  (Bioss)
94
Bioss endothelial lined blood vessel marker
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Endothelial Lined Blood Vessel Marker, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endothelial lined blood vessel marker/product/Bioss
Average 94 stars, based on 1 article reviews
endothelial lined blood vessel marker - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
msc related markers cd34  (Cyagen Biosciences)
94
Cyagen Biosciences msc related markers cd34
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Msc Related Markers Cd34, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msc related markers cd34/product/Cyagen Biosciences
Average 94 stars, based on 1 article reviews
msc related markers cd34 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
surface marker verification cd34  (Cyagen Biosciences)
94
Cyagen Biosciences surface marker verification cd34
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Surface Marker Verification Cd34, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/surface marker verification cd34/product/Cyagen Biosciences
Average 94 stars, based on 1 article reviews
surface marker verification cd34 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
cd34 surface markers  (ZenBio)
90
ZenBio cd34 surface markers
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Cd34 Surface Markers, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 surface markers/product/ZenBio
Average 90 stars, based on 1 article reviews
cd34 surface markers - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
phycoerythrin (pe)-conjugated monoclonal antibodies against normal pattern mesenchymal markers (cd105, cd90, cd73, cd45, and cd34)  (Becton Dickinson)
90
Becton Dickinson phycoerythrin (pe)-conjugated monoclonal antibodies against normal pattern mesenchymal markers (cd105, cd90, cd73, cd45, and cd34)
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Phycoerythrin (Pe) Conjugated Monoclonal Antibodies Against Normal Pattern Mesenchymal Markers (Cd105, Cd90, Cd73, Cd45, And Cd34), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phycoerythrin (pe)-conjugated monoclonal antibodies against normal pattern mesenchymal markers (cd105, cd90, cd73, cd45, and cd34)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
phycoerythrin (pe)-conjugated monoclonal antibodies against normal pattern mesenchymal markers (cd105, cd90, cd73, cd45, and cd34) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
msc markers cd34 santa cruz, cat. no: sc-74499  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology msc markers cd34 santa cruz, cat. no: sc-74499
In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for <t>endothelial</t> vessels using <t>CD34.</t> Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance
Msc Markers Cd34 Santa Cruz, Cat. No: Sc 74499, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msc markers cd34 santa cruz, cat. no: sc-74499/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
msc markers cd34 santa cruz, cat. no: sc-74499 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cd34 cell marker  (Thermo Fisher)
90
Thermo Fisher cd34 cell marker
Phenotype identification of MSCs. ( A ) Negative surface markers (CD34, CD45, and HLA-DR) identification of MSCs. ( B ) Positive surface markers (CD44, <t>CD73,</t> and CD90) identification of MSCs.
Cd34 Cell Marker, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 cell marker/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
cd34 cell marker - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cd34 marker  (Becton Dickinson)
90
Becton Dickinson cd34 marker
Phenotype identification of MSCs. ( A ) Negative surface markers (CD34, CD45, and HLA-DR) identification of MSCs. ( B ) Positive surface markers (CD44, <t>CD73,</t> and CD90) identification of MSCs.
Cd34 Marker, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 marker/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd34 marker - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for endothelial vessels using CD34. Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance

Journal: Signal Transduction and Targeted Therapy

Article Title: Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapies

doi: 10.1038/s41392-025-02186-y

Figure Lengend Snippet: In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in 4T1 in situ tumor-bearing Balb/c mice. a Scheme of 4T1 in situ tumor-bearing mice model establishment and treatment procedure. b Excised tumors from mice in each group. c Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. d The excised tumor volumes of mice from each group. n = 6 per group. e The excised tumor weights of mice from each group. n = 6 per group. f H&E staining of 4T1 tumors from different treatment groups. IHC staining of 4T1 tumors from different treatment groups for cell proliferation using Ki67 and for endothelial vessels using CD34. Scale bars: 100 μm. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns means no statistical significance

Article Snippet: Labeling proliferation marker (Ki67, bsm-60738R, Bioss USA) and endothelial-lined blood vessel marker (CD34, bs-8996R, Bioss USA) antibodies were used for IHC analyses.

Techniques: In Vivo, In Situ, Staining, Immunohistochemistry

In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in the PDX TNBC models. a Scheme of PDX model establishment and treatment procedure. b Tumor growth curves of the PDX mouse models. n = 6 per group. c Image of excised tumors after treatment on day 38. d Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. e Excised tumor volume of different treatment groups. n = 6 per group. f Excised tumor weight of different treatment groups. n = 6 per group. g Ki67 and CD34 IHC staining of tumors from mice administered various treatments. n = 3 per group. Scale bars: 100 μm. h The IHC quantification results in each treatment group. n = 3 per group. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Signal Transduction and Targeted Therapy

Article Title: Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapies

doi: 10.1038/s41392-025-02186-y

Figure Lengend Snippet: In vivo anti-tumor efficacy of photodynamic gel-bombs (DCM@OPR) in the PDX TNBC models. a Scheme of PDX model establishment and treatment procedure. b Tumor growth curves of the PDX mouse models. n = 6 per group. c Image of excised tumors after treatment on day 38. d Relative tumor volumes over time in mice from different treatment groups. n = 6 per group. e Excised tumor volume of different treatment groups. n = 6 per group. f Excised tumor weight of different treatment groups. n = 6 per group. g Ki67 and CD34 IHC staining of tumors from mice administered various treatments. n = 3 per group. Scale bars: 100 μm. h The IHC quantification results in each treatment group. n = 3 per group. Data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: Labeling proliferation marker (Ki67, bsm-60738R, Bioss USA) and endothelial-lined blood vessel marker (CD34, bs-8996R, Bioss USA) antibodies were used for IHC analyses.

Techniques: In Vivo, Immunohistochemistry

Phenotype identification of MSCs. ( A ) Negative surface markers (CD34, CD45, and HLA-DR) identification of MSCs. ( B ) Positive surface markers (CD44, CD73, and CD90) identification of MSCs.

Journal: Microbiology Spectrum

Article Title: Unraveling the interplay between mesenchymal stem cells, gut microbiota, and systemic sclerosis: therapeutic implications

doi: 10.1128/spectrum.01576-24

Figure Lengend Snippet: Phenotype identification of MSCs. ( A ) Negative surface markers (CD34, CD45, and HLA-DR) identification of MSCs. ( B ) Positive surface markers (CD44, CD73, and CD90) identification of MSCs.

Article Snippet: MSCs were determined by flow cytometry analysis of the specific markers before use, including CD90, CD44, CD73, CD34, CD45, and HLA-DR (eBioscience, California, USA) on MSCs.

Techniques: